APA (7th ed.) Citation

ED, F., MJ, D., R, S., & E, W. (2018). Diastolic dysfunction in pulmonary artery hypertension: Creatine kinase and the potential therapeutic benefit of beta-blockers. Clinical and experimental pharmacology & physiology, 45(4), 384. https://doi.org/10.1111/1440-1681.12898

Chicago Style (17th ed.) Citation

ED, Fowler, Drinkhill MJ, Stones R, and White E. "Diastolic Dysfunction in Pulmonary Artery Hypertension: Creatine Kinase and the Potential Therapeutic Benefit of Beta-blockers." Clinical and Experimental Pharmacology & Physiology 45, no. 4 (2018): 384. https://doi.org/10.1111/1440-1681.12898.

MLA (9th ed.) Citation

ED, Fowler, et al. "Diastolic Dysfunction in Pulmonary Artery Hypertension: Creatine Kinase and the Potential Therapeutic Benefit of Beta-blockers." Clinical and Experimental Pharmacology & Physiology, vol. 45, no. 4, 2018, p. 384, https://doi.org/10.1111/1440-1681.12898.